Brown Rudnick advised EDX Medical Group plc, a developer of innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, on its share-for-share acquisition of Oxford-based Hutano Diagnostics Ltd, a developer of ‘point of care’ testing devices suitable for qualitative and quantitative assessment of single and multiple compounds. […]
The post Brown Rudnick Advises EDX Medical in Acquisition of Hutano Diagnostics appeared first on Legal Desire Media and Insights.